Tevogen Bio Holdings Inc. (TVGN) Financials

$0.67

south_east
-$0.11 (-13.54%)
Day's range
$0.65
Day's range
$0.79

TVGN Income statement / Annual

Last year (2024), Tevogen Bio Holdings Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Tevogen Bio Holdings Inc.'s net income was -$10.11 M. See Tevogen Bio Holdings Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Operating Revenue $0.00 $0.00 $0.00 $0.00
Cost of Revenue $403.58 K $378.36 K $0.00 $0.00
Gross Profit -$403.58 K -$378.36 K $0.00 $0.00
Gross Profit Ratio 0 0 0 0
Research and Development Expenses $31.03 M $4.40 M $0.00 $2.96 M
General & Administrative Expenses $0.00 $0.00 $0.00 $1.66 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $22.13 M $4.06 M $953.08 K $1.66 M
Other Expenses $0.00 $0.00 $0.00 $0.00
Operating Expenses $53.16 M $8.46 M $953.08 K $4.62 M
Cost And Expenses $53.56 M $8.84 M $953.08 K $4.62 M
Interest Income $0.00 $0.00 $0.00 $0.00
Interest Expense $184.04 K $256.03 K $0.00 $598.50 K
Depreciation & Amortization $403.58 K $378.36 K $0.00 $9.38 K
EBITDA -$13.14 M -$58.89 M $4.41 M -$14.99 M
EBITDA Ratio 0 0 0 0
Operating Income Ratio 0 0 0 0
Total Other Income/Expenses Net $39.84 M -$51.63 M $5.36 M -$10.98 M
Income Before Tax -$13.73 M -$60.48 M $4.41 M -$15.60 M
Income Before Tax Ratio 0 0 0 0
Income Tax Expense $0.00 $0.00 $0.00 $0.00
Net Income -$10.11 M -$60.48 M $4.41 M -$15.60 M
Net Income Ratio 0 0 0 0
EPS -0.0936 -0.0004 0.0367 -0.33
EPS Diluted -0.0936 -0.0004 0.0367 -0.33
Weighted Average Shares Out $146.67 M $165.42 M $120.00 M $47.93 M
Weighted Average Shares Out Diluted $146.67 M $165.42 M $120.00 M $47.93 M
Link